Frankfurt am Main, Germany

Isabell Schoettle

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Isabell Schoettle

Introduction: Isabell Schoettle, an accomplished inventor based in Frankfurt am Main, Germany, has made significant contributions to the fields of pharmaceuticals and biotechnology. With two patents to her name, her work focuses on innovative solutions for treating cartilage diseases and joint injuries.

Latest Patents: Isabell's latest patents include groundbreaking inventions that enhance medical treatments. One of her notable patents is titled "Expression and folding in the manufacturing process of CD-RAP by using a CD-RAP precursor protein." This invention details a CD-RAP precursor protein that incorporates both a pre-sequence and CD-RAP, which is utilized for the production of native CD-RAP. The patent also discusses the development of compositions comprising CD-RAP alongside positively charged amino acids and buffers, aimed at treating conditions related to cartilage disease, such as aggrecan degradation and joint issues.

Another patent focuses on a "Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine." This liquid composition is designed as an add-on therapy for diabetes patients, combining a GLP-1 agonist or a pharmacologically tolerable salt, insulin, and methionine for enhanced therapeutic effect.

Career Highlights: Isabell has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis Deutschland GmbH and Bionet Pharma GmbH. Her experience in these organizations has allowed her to refine her expertise and contribute to pioneering research and development.

Collaborations: Throughout her career, Isabell has collaborated with talented professionals, including her coworkers Annika Hagendorf and Gerrit Hauck. These partnerships have fostered innovation and spurred the development of her patented technologies.

Conclusion: Isabell Schoettle continues to be a trailblazer in the field of biotechnology, with her work significantly impacting the treatment of cartilage diseases and metabolic disorders. Her inventive spirit and dedication to research exemplify the qualities of a visionary inventor, making her a notable figure in the sphere of pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…